AIA Investment Management’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
$99K Buy
576
+144
+33% +$26.6K 0.02% 235
2020
Q2
$83K Sell
432
-191
-31% -$31.3K 0.02% 189
2020
Q1
$92K Buy
623
+98
+19% +$15.6K 0.02% 166
2019
Q4
$81K Buy
525
+328
+166% +$47.3K 0.1% 147
2019
Q3
$27K Buy
+197
New +$25.8K 0.03% 245

Other funds holding RMD

AIA Investment Management's RMD Position: Q3 2020 in Review

AIA Investment Management increased its ResMed (RMD) stake by 33% in Q3 2020, buying an estimated $26.6K and bringing the position to 576 shares worth $99K. The position accounts for 0.02% of the portfolio, ranked #235.

AIA Investment Management first reported a position in RMD in Q3 2019 and has held it in 5 quarters since. 626 funds tracked by Wall St. Rank hold RMD as of Q3 2020.

  • AIA Investment Management held 576 shares of ResMed worth $99K as of Q3 2020.
  • AIA Investment Management bought 144 ResMed shares in Q3 2020, an estimated $26.6K.
  • ResMed made up 0.02% of AIA Investment Management's portfolio in Q3 2020, its #235 holding.
  • AIA Investment Management first reported a position in ResMed in Q3 2019 and has held it in 5 quarters since.
  • 626 funds tracked by Wall St. Rank held ResMed as of Q3 2020.

Based on AIA Investment Management's 13F filing for Q3 2020, filed 16 Nov 2020.